LNLuca Narduzzi

Luca Narduzzi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luca Narduzzi has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Metabolome Atlas of Grape Biodiversity

    by Panagiotis Arapitsas, Pietro Franceschi, Mar Garcia-Aloy, Urska Vrhovsek, Luca Narduzzi, Domenico Masuero, Marco Stefanini, Paola Bettinelli, Maria Stella Grando, Francesco Emanuelli, et al.

    Grapevine (Vitis spp.) is one of the world’s most economically, culturally, and biologically important fruit crops, with remarkable diversity spanning thousands of V. vinifera cultivars together with rootstocks and wild relatives. Yet grapevine biodiversity has never been systematically explored at the metabolome scale, despite its importance for chemotaxonomy, breeding, and sustainable viticulture. Here, we present the Grape Metabolome (GM) Project, the first systematic liquid chromatography–mass spectrometry (LC–MS) survey of grapevine biodiversity, comprising 462 samples from 126 accessions collected across four vintages. Advanced and well-established chemometric tools resolved the major grape chemotypes together with finer cultivar-related substructure, while annotation-guided interpretation linked this organization to distinctive patterns in anthocyanins, flavonols, aroma-related compounds, and tannin-associated phenolics. This data set provides a reference framework for chemotaxonomy, breeding, authenticity, precision viticulture and enology.

  • Open Access

    Deeper insights into the effects of low dietary levels of polychlorinated biphenyls on pig metabolism using gas chromatography-high resolution mass spectrometry metabolomics

    by Luca Narduzzi, Maykel Hernández-Mesa, Pauline Vincent, Yann Guitton, Ana M. García-Campaña, Bruno Le Bizec, Gaud Dervilly


  • Open Access

    A comparison of hydrophilic interaction liquid chromatography and capillary electrophoresis for the metabolomics analysis of human serum

    by Luca Narduzzi, María del Mar Delgado-Povedano, Francisco J. Lara, Bruno Le Bizec, Ana María García-Campaña, Gaud Dervilly, Maykel Hernández-Mesa


  • Metabolomics and lipidomics to identify biomarkers of effect related to exposure to non-dioxin-like polychlorinated biphenyls in pigs

    by Maykel Hernández-Mesa, Luca Narduzzi, Sadia Ouzia, Nicolas Soetart, Laetitia Jaillardon, Yann Guitton, Bruno Le Bizec, Gaud Dervilly


  • Open Access

    Coupling Complete Blood Count and Steroidomics to Track Low Doses Administration of Recombinant Growth Hormone: An Anti-Doping Perspective

    by Luca Narduzzi, Corinne Buisson, Marie-Line Morvan, Alexandre Marchand, Michel Audran, Yves Le Bouc, Emmanuelle Varlet-Marie, Magnus Ericsson, Bruno Le Bizec, Gaud Dervilly

    Growth Hormone (GH) under its human recombinant homologue (rhGH), may be abused by athletes to take advantage of its well-known anabolic and lipolytic properties; hence it is prohibited in sports by the World Anti-Doping Agency. Due to the rapid turnover of rhGH, anti-doping screening tests have turned to monitor two endocrine biomarkers (IGF-I and P-III-NP), but unfortunately, they show population-wise variability, limiting the identification rate of rhGH users. Previous studies have evidenced the numerous effects of GH on human physiology, especially in hematopoiesis and steroidogenesis. In this work, aiming to discover novel physiological rhGH biomarkers, we analyzed the complete blood count and the steroidomics profile of healthy, physically active, young males treated either with EPO + rhGH or EPO + placebo. The time-trends of these two physiological routes have been analyzed through geometric trajectory analysis (GTA) and OPLS-DA. Individuals supplemented with micro-doses of rhGH exhibited different leukopoietic and steroidal profiles compared to the control population, suggesting a role of the rhGH in both pathways. In the article, hypotheses on the observed differences are discussed according to the most recent literature and compared to results in animal models. The use of leukopoietic and steroidal biomarkers together with endocrine biomarkers (IGF-1 and P-III-NP) allows to correctly classify over 98% of samples with no false positives, miss-classifying only one single sample (false negative) over a total of 56; a promising result, if compared to the current rhGH detection strategies.


  • Non-targeted screening methodology to characterise human internal chemical exposure: Application to halogenated compounds in human milk

    by Mariane Pourchet, Luca Narduzzi, Annabelle Jean, Ingrid Guiffard, Emmanuelle Bichon, Ronan Cariou, Yann Guitton, Sébastien Hutinet, Jelle Vlaanderen, Jeroen Meijer, et al.


  • Applying metabolomics to detect growth hormone administration in athletes: Proof of concept

    by Luca Narduzzi, Gaud Dervilly, Alexandre Marchand, Michel Audran, Bruno Le Bizec, Corinne Buisson

    Growth hormone (GH), an endogenous peptide regulating anabolism and lipolysis in humans, is known to be abused by athletes to improve their performance. Despite the development of two distinct screening methods, few positive cases have been reported by the antidoping authorities, probably due to the quick turnover of GH and the masking effects of age, ethnicity, and sex. Apart from growth regulation, GH is known to affect several metabolic pathways in humans including ketosis, amino‐acid uptake, and protein breakdown. It is reasonable to imagine observing its markers of effects through the leading tool on metabolism study, metabolomics. In this proof‐of‐concept study, a cohort of well‐trained volunteers was split in two equal groups and administered with micro‐doses of EPO or EPO + GH every second day for 2 weeks. Urine and plasma samples were collected before, during, and after treatment and analyzed using metabolomics and lipidomics approaches. The results show that, by applying a direct discriminant analysis on the treated groups, it is possible to distinguish the treatments, and to use this difference to classify them correctly. High intragroup variability is observed, due to the subject‐specific effect of the hormones. Through time 0 centering the data, a longitudinally tracking of the group was performed and a higher difference was observed between the groups, including a perfect classification of the samples before and after the treatments.


  • A role for metabolomics in the antidoping toolbox?

    by Luca Narduzzi, Gaud Dervilly, Michel Audran, Bruno Le Bizec, Corinne Buisson

    The evidence of continuous rise of novel doping agents and novel doping strategies calls for the development of more accurate multi‐target screening methods. Direct multi‐target screening approaches are restricted to the targeted substances and their turnover. The development of effective “indirect” screening methods requires a priori deep‐understanding of the substance metabolism. The biological passport has been demonstrated to be very effective, but it is limited to about 20 indirect parameters. The standard anti‐doping analytical methods are hence targeted and does not aim to directly identify unknown substances. Also, the detection of doping agents is limited by the substances excretion. We propose to consider metabolomics for screening of abuse of performance enhancing hormones by athletes, with the basis on the following pieces of evidence: 1) Hormones have a strong influence on human metabolism, changing several parameters in many tissues, organs, and bio‐fluids. 2) Metabolomics has been demonstrated to be a very accurate tool to depict the metabolic status of several organisms, tissues and for several human diseases, including hormonal deficiencies. 3) Metabolomics has been demonstrated to be able to distinguish hormone‐treated animals from controls in many species, without the need of a priori knowledge of the metabolism for the specific substance. The literature shows that metabolomics could be an appropriate tool to detect hormonal abuse, keeping in mind the strength and the limitation of such an approach.


  • Open Access

    Ammonium Fluoride as Suitable Additive for HILIC-Based LC-HRMS Metabolomics

    by Luca Narduzzi, Anne-Lise Royer, Emmanuelle Bichon, Yann Guitton, Corinne Buisson, Bruno Le Bizec, Gaud Dervilly-Pinel

    Hydrophilic Interaction Liquid Chromatography (HILIC) chromatography is widely applied in metabolomics as a complementary strategy to reverse phase chromatography. Nevertheless, it still faces several issues in terms of peak shape and compounds ionization, limiting the automatic de-convolution and data semi-quantification performed through dedicated software. A way to improve the chromatographic and ionization performance of a HILIC method is to modify the electrostatic interactions of the analytes with both mobile and stationary phases. In this study, using a ZIC-HILIC chromatographic phase, we evaluated the performance of ammonium fluoride (AF) as additive salt, comparing its performance to ammonium acetate (AA). Three comparative criteria were selected: (1) identification and peak quality of 34 standards following a metabolomics-specific evaluation approach, (2) an intraday repeatability test with real samples and (3) performing two real metabolomics fingerprints with the AF method to evaluate its inter-day repeatability. The AF method showed not only higher ionization efficiency and signal-to-noise ratio but also better repeatability and robustness than the AA approach. A tips and tricks section is then added, aiming at improving method replicability for further users. In conclusion, ammonium fluoride as additive salt presents several advantages and might be considered as a step forward in the application of robust HILIC methods in metabolomics.


  • The Compound Characteristics Comparison (CCC) approach: a tool for improving confidence in natural compound identification

    by Luca Narduzzi, Jan Stanstrup, Fulvio Mattivi, Pietro Franceschi

    Compound identification is the main hurdle in LC-HRMS-based metabolomics, given the high number of 'unknown' metabolites. In recent years, numerous in silico fragmentation simulators have been developed to simplify and improve mass spectral interpretation and compound annotation. Nevertheless, expert mass spectrometry users and chemists are still needed to select the correct entry from the numerous candidates proposed by automatic tools, especially in the plant kingdom due to the huge structural diversity of natural compounds occurring in plants. In this work, we propose the use of a supervised machine learning approach to predict molecular substructures from isotopic patterns, training the model on a large database of grape metabolites. This approach, called 'Compounds Characteristics Comparison' (CCC) emulates the experience of a plant chemist who 'gains experience' from a (proof-of-principle) dataset of grape compounds. The results show that the CCC approach is able to predict with good accuracy most of the sub-structures proposed. In addition, after querying MS/MS spectra in Metfrag 2.2 and applying CCC predictions as scoring terms with real data, the CCC approach helped to give a better ranking to the correct candidates, improving users' confidence in candidate selection. Our results demonstrated that the proposed approach can complement current identification strategies based on fragmentation simulators and formula calculators, assisting compound identification. The CCC algorithm is freely available as R package (https://github.com/lucanard/CCC) which includes a seamless integration with Metfrag. The CCC package also permits uploading additional training data, which can be used to extend the proposed approach to other systems biological matrices. List of abbreviations: Acidic: acidic moiety; aliph: aliphatic chain; AUC: area under the ROC curve; bs: best glycosidic structure; CCC: Compounds' Characteristics Comparison; Cees: Carbons estimation errors; CO: Carbon to Oxygen ratio; Het: Heterocyclic moiety; IMD: Isotopic Mass Defect (and Pattern); LC-HRMS: Liquid Chromatography - High Resolution Mass Spectrometry; md: mass defect; MM: Monoisotopic Mass; MS: Mass Spectrometry; MSE: Mean Squared Error; nC: number of Carbons; NN: Nitrogen; pC: percentage of Carbon mass on the total mass; Pho: Phosphate; PLSr: Partial Least Square regression; ppm: parts per million; QSRR: Quantitative structure-retention relationship; RMD: Relative Mass Defect; ROC: Receiver Operating Characteristics; rRMD: residual Relative Mass Defect; RT: retention time; Sul: Sulphur; UPLC-ESI-Q-TOF-MS: Ultra Performance Liquid Chromatography - ElectroSpray Ionization -Quadropole - Time of Flight - Mass Spectrometry; VAT: Vitis arizonica Texas.